Gastrointestinal Cancer News

A novel monocyte-derived cell therapy showed evidence of migrating from the blood to the tumor microenvironment for several solid tumor types, according to phase 1 study results.

WASHINGTON — Increased culturally competent care and improved access to medical transport may improve early detection of hepatocellular carcinoma in patients who live in late-stage hotspots, according to researchers at The Liver Meeting.

A study presented at this year’s ASCO Quality Care Symposium examined predictors of compliance with payer-led oncology clinical pathways.

Racial and ethnic disparities in enrollment of patients to early-phase metastatic cancer-drug clinical trials worsened between 2000 and 2018, according to study results published in JAMA Network Open.

For centuries, psychedelic plants and fungi have been harvested and explored for medicinal purposes.

The FDA granted orphan drug designation to OTX-2002 for the treatment of hepatocellular carcinoma, according to the agent’s manufacturer.

Octreotide acetate injection 500 µg/mL has been voluntarily recalled due to the presence of glass particles in a syringe, according to a press release.

CHARLOTTE, N.C. — Endoscopic ultrasound-guided radiofrequency ablation, alone or combined with chemotherapy, improved survival and progression-free survival among a small subset of patients with primary pancreatic ductal adenocarcinoma.

CHARLOTTE, N.C. — Achalasia was associated with an increased risk for esophageal cancer among a cohort of veterans, suggesting the need for increased endoscopic surveillance, according to a presenter at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Elevated baseline neutrophil-to-lymphocyte ratio was associated with distant metastases and poor survival in patients with gastric cancer, according to a presenter at the ACG Annual Scientific Meeting.